WuXi AppTec Reports Record First-Half Results in 2022

/PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable...

Related Keywords

China ,Lingang ,Jiangxi ,Shanghai ,United States ,Wuxi ,Jiangsu ,Hong Kong ,Changzhou ,America , ,Half Report Of The Company ,International Financial Reporting Standards ,Stock Exchange Of Hong Kong ,Owners Of The Company ,Shanghai Stock Exchange ,Wuxi Apptec Co Ltd ,Manufacturing Organization ,Contract Research ,Site Management Organization ,Accounting Standard For Business Enterprises ,Profit Attributable ,Earnings Per Share ,Stock Exchange ,Half Report ,Wuxi Apptec ,Accounting Standard ,Business Enterprises ,Contract Testing ,Reporting Period ,Wuxi Chemistry ,Wuxi Testing ,Wuxi Apptec Investigational New Drug ,Wuxi Biology ,North America ,Shanghai Lingang ,Tetracycline Enabled Self Silencing Adenovirus ,Financial Position ,Net Profit Attributable ,